Impact of established cardiovascular disease on outcomes in the Global Leaders trial
Author(s) Garg S.; Chichareon P.; Modolo R.; Tomaniak M.; Onuma Y. et al.
Source European Heart Journal; Oct 2019; vol. 40 ; p. 3108
Objectives: To investigate the impact of ticagrelor monotherapy following one-month dual antiplatelet therapy (DAPT) on clinical outcomes after percutaneous coronary intervention (PCI) in patients with established cardiovascular disease (CVD) who were enrolled in the Global Leaders Trial.
Leave a Reply.
The following databases were searched:
EMBASE, MEDLINE, PsycINFO, BNI, CINAHL,
to find ELHT staff publications
Learning Centre Library
Royal Blackburn Teaching Hospital
01254 734312 or Ext 84312
Burnley General Teaching Hospital
01282 803114 or Ext. 13114
Staffed Opening Hours
24/7 access to both libraries is available - please see library staff